Happiness Development Group Limited
NASDAQ Capital MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Happiness Development Group Limited (NASDAQ:HAPP) engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally; its core offerings include lucidum spore powders, cordyceps mycelia, Ejiao products, American ginseng products, other traditional Chinese herbal and animal extracts, vitamins, minerals, and amino acids under the Happiness brand, sold through distributors, large-scale chain drugstores, malls, and supermarkets. The company also provides product marketing and e-commerce agency operation services under the Happy Buy platform to small- and medium-sized businesses; e-commerce solutions, internet information, and advertising services to online stores or manufacturers; and secure transaction environments, automobile procurement, and financial services for automobile manufacturers under the Taochejun automobile sales platform. Founded in 2004 and headquartered in Nanping, Fujian Province, People's Republic of China, Happiness Development Group Limited operates subsidiaries including Fujian Happiness Biotech Co., Happiness Biology Technology Group Ltd., Happiness (Nanping) Biotech Co., and Shunchang Happiness Nutraceutical Co. In October 2022, the company changed its name from Happiness Biotech Group Limited to reflect its expanded business lines beyond nutraceuticals into e-commerce and automobile sales; in April 2023, it entered a share purchase agreement disposing of Fujian Happiness Biotech Co. to Fujian Hengda Beverage Co., Ltd. for RMB 78 million; and on July 5, 2024, it sold 100% equity interests in Happiness Hong Kong and its subsidiaries, including the e-commerce and automobile sales operating entities, to a non-affiliate individual. The company maintains its NASDAQ listing under the HAPP ticker symbol as of late 2025, with ongoing operations focused on healthcare products amid strategic divestitures to streamline its portfolio.
How to Find the Best Penny Stocks to Buy in 2022
Hot Penny Stocks to Buy This Week? 3 to Watch
HAPP Stock Soars 38% as Happiness Development Embraces EVs
Happiness Biotech Enters $14M Electric Vehicle Transaction With Ruili
Happiness Biotech Announced Another Electric Vehicle Transaction of Over $14 Million With Ruili
Happiness Biotech Announced The Launch of Its Lucidum Tablets on DouYin Mall
Happiness Biotech Announces $2.16 Million Registered Direct Offering To Strategic Investors
Happiness Biotech Launched Beta Version Of Happy Buy International, Promoting Cross-border E-Commerce SaaS Services
Happiness Biotech Signed Agreement To Distribute Volkswagen Electric Vehicles
A Trio of Net Current Asset Value Stock Picks
HAPP Stock Alert: 4 Things to Know About Happiness Biotech Group as Shares Soar Today
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data
The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology